Fazekas-Lavu Monika, Parker Andrew, Spigelman Allan D, Scott Rodney J, Epstein Richard J, Jensen Michael, Samaras Katherine
Department of Endocrinology.
Department of Pathology, St Vincent's Hospital, Darlinghurst, NSW, Australia.
Ther Clin Risk Manag. 2017 Jul 21;13:915-918. doi: 10.2147/TCRM.S121812. eCollection 2017.
Lynch syndrome describes a familial cancer syndrome comprising germline mutations in one of four DNA mismatch repair genes, , , , and and is characterized by colorectal, endometrial, and other epithelial malignancies. Thyroid cancer is not usually considered to be part of the constellation of Lynch syndrome cancers nor have Lynch syndrome tumor gene mutations been reported in thyroid malignancies. This study reports a woman with Lynch syndrome (colonic cancer and a DNA mismatch repair mutation in the gene) with a synchronous papillary thyroid cancer. Six years later, she developed metachronous breast cancer. Metastatic bone disease developed after 3 years, and the disease burden was due to both breast and thyroid diseases. Despite multiple interventions for both metastatic breast and thyroid diseases, the patient's metastatic burden progressed and she died of leptomeningeal metastatic disease. Two prior case reports suggested thyroid cancer may be an extraintestinal malignancy of the Lynch syndrome cancer group. Hence, this study examined the genetic relationship between the patient's known Lynch syndrome and her thyroid cancer. The thyroid cancer tissue showed normal expression of , suggesting that the tumor was not due to the oncogenic mutation of Lynch syndrome, and molecular analysis confirmed mutation. Although in this case the thyroid cancer was sporadic, it raises the importance of considering cancer genetics in familial cancer syndromes when other cancers do not fit the criteria of the syndrome. Careful documentation of other malignancies in patients with thyroid cancer and their families would assist in better understanding of any potential association. Appropriate genetic testing will clarify whether a common pathogenic mechanism links seemingly unrelated cancers.
林奇综合征是一种家族性癌症综合征,由四个DNA错配修复基因( 、 、 、 )中的一个发生种系突变组成,其特征为结直肠癌、子宫内膜癌和其他上皮性恶性肿瘤。甲状腺癌通常不被认为是林奇综合征相关癌症的一部分,甲状腺恶性肿瘤中也未报告过林奇综合征肿瘤基因突变。本研究报告了一名患有林奇综合征(结肠癌且 基因存在DNA错配修复突变)并同时患有乳头状甲状腺癌的女性。六年后,她又患上了异时性乳腺癌。3年后出现转移性骨病,疾病负担是由乳腺癌和甲状腺癌共同导致的。尽管对转移性乳腺癌和甲状腺癌都进行了多次干预,但患者的转移负担仍在进展,最终死于软脑膜转移疾病。之前的两份病例报告表明,甲状腺癌可能是林奇综合征癌症组的一种肠外恶性肿瘤。因此,本研究检查了患者已知的林奇综合征与其甲状腺癌之间的遗传关系。甲状腺癌组织显示 表达正常,表明该肿瘤并非由林奇综合征的致癌突变引起,分子分析证实存在 突变。虽然在这个病例中甲状腺癌是散发性的,但当其他癌症不符合该综合征标准时,这凸显了在家族性癌症综合征中考虑癌症遗传学的重要性。仔细记录甲状腺癌患者及其家族中的其他恶性肿瘤情况,将有助于更好地理解任何潜在关联。适当的基因检测将阐明看似不相关的癌症是否存在共同的致病机制。